Coherus Biosciences | Capitale Sociale E Riserve

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -2.64B 2.46B 2025-09
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Akebia Therapeutics USD 41.59M 12.37M 2025-09
ALKERMES USD 1.73B 108.85M 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Amarin USD 458.89M 6.03M 2025-09
Amgen USD 9.62B 2.19B 2025-09
Baxter International USD 7.24B 79M 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 87.77M 32.05M 2025-09
Eli Lilly USD 23.79B 5.52B 2025-09
Fujifilm JPY 3.72T 230.16B 2025-12
Gilead Sciences USD 21.46B 1.78B 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Merck USD 51.85B 2.79B 2025-09
Myriad Genetics USD 372.8M 15.3M 2025-09
Pacira USD 727.21M 30.55M 2025-09
Perrigo USD 4.45B 25.8M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09
Xencor USD 625.32M 4.96M 2025-09
Zoetis USD 5.4B 421M 2025-09


Coherus Biosciences Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.